Glenmede Trust’s Xometry XMTR Stock Holding History

Glenmede Trust’s Portfolio XMTR Stock Details XMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,753	Closed	-$499K	–	1406
2021 Q4	$499K	Buy	+9,753	New	+$502K	﹤0.01%	925

Other funds holding XMTR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HMP9

Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return

Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Glenmede Trust's XMTR Position: Q1 2022 in Review

Glenmede Trust sold out of Xometry (XMTR) in Q1 2022, closing a stake of 9,753 shares — an estimated $499K sold.

Glenmede Trust first reported a position in XMTR in Q4 2021 and held it in 1 quarter. The position peaked at $499K in Q4 2021. 124 funds tracked by Wall St. Rank hold XMTR as of Q1 2022.

Glenmede Trust reported no remaining Xometry position as of Q1 2022 after selling out during the quarter.
Glenmede Trust sold 9,753 Xometry shares in Q1 2022, an estimated $499K.
Glenmede Trust first reported a position in Xometry in Q4 2021 and held it in 1 quarter.
Glenmede Trust's Xometry position peaked at $499K in Q4 2021.
124 funds tracked by Wall St. Rank held Xometry as of Q1 2022.

Based on Glenmede Trust's 13F filing for Q1 2022, filed 16 May 2022.